Outlook Wealth Advisors LLC Acquires New Position in Intuitive Surgical, Inc. $ISRG

Outlook Wealth Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 396 shares of the medical equipment provider’s stock, valued at approximately $215,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. FineMark National Bank & Trust grew its stake in shares of Intuitive Surgical by 2.3% during the second quarter. FineMark National Bank & Trust now owns 24,194 shares of the medical equipment provider’s stock worth $13,147,000 after purchasing an additional 539 shares during the period. Birchbrook Inc. boosted its holdings in Intuitive Surgical by 2,215.9% during the second quarter. Birchbrook Inc. now owns 1,459 shares of the medical equipment provider’s stock worth $793,000 after buying an additional 1,396 shares during the last quarter. Wealthspire Advisors LLC grew its position in shares of Intuitive Surgical by 21.7% during the 2nd quarter. Wealthspire Advisors LLC now owns 2,033 shares of the medical equipment provider’s stock worth $1,105,000 after buying an additional 362 shares during the period. Perennial Investment Advisors LLC increased its stake in shares of Intuitive Surgical by 6.9% in the 2nd quarter. Perennial Investment Advisors LLC now owns 2,587 shares of the medical equipment provider’s stock valued at $1,406,000 after acquiring an additional 166 shares during the last quarter. Finally, Portside Wealth Group LLC raised its position in shares of Intuitive Surgical by 13.8% in the 2nd quarter. Portside Wealth Group LLC now owns 1,891 shares of the medical equipment provider’s stock valued at $1,028,000 after acquiring an additional 230 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG stock opened at $546.77 on Wednesday. The stock has a market capitalization of $196.00 billion, a P/E ratio of 72.32, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The business has a 50-day moving average of $485.63 and a 200-day moving average of $503.34.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the firm earned $1.84 EPS. Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on ISRG shares. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a report on Thursday, October 23rd. The Goldman Sachs Group boosted their price target on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Leerink Partners raised their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Mizuho set a $575.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. Finally, Evercore ISI increased their price target on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $608.92.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 7,562 shares of the stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at $193,595.79. This represents a 95.54% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 116,164 shares of company stock valued at $61,916,172 in the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.